Compare SCWO & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | SCWO | IXHL |
|---|---|---|
| Founded | 2021 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Environmental Services | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 37.0M |
| IPO Year | 2022 | 2024 |
| Metric | SCWO | IXHL |
|---|---|---|
| Price | $2.44 | $3.58 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 52.3K | ★ 78.5K |
| Earning Date | 05-14-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.41 | N/A |
| Revenue | ★ $215,037.00 | $12,000.00 |
| Revenue This Year | $25,798.80 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.85 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.19 | $0.16 |
| 52 Week High | $3.60 | $6.39 |
| Indicator | SCWO | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 57.67 | 67.22 |
| Support Level | $2.35 | $2.79 |
| Resistance Level | $2.81 | $3.68 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 50.82 | 91.67 |
374Water Inc is a cleantech and environmental services company developing SCWO for the destruction of organic waste streams within the municipal, federal, and industrial markets. It offers its proprietary AirSCWO technology, which is designed to efficiently destroy and mineralize a broad spectrum of non-hazardous and hazardous organic wastes producing safe dischargeable water streams, safe mineral effluent, safe vent gas, and recoverable heat energy. Its AirSCWO technology is designed to effectively convert solid and liquid wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, including forever chemicals into inert and recoverable resources including water, minerals, and heat energy.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.